Scotland’s TCB inks CAR-T deal with Japan’s NIPRO
admin 7th February 2018 Uncategorised 0Scotland’s TC Biopharm (TCB) has secured a major investment from Japan with a deal centered on developing a novel gamma-delta CAR-T therapy to treat cancer, as well as a grant from Scottish Enterprise worth £2.7 million to fund preclinical activities.
More: Scotland’s TCB inks CAR-T deal with Japan’s NIPRO
Source: News